KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)

KMPHARMACEUTICAL Revenue

KMPHARMACEUTICAL had revenue of 4.47B KRW in the quarter ending March 31, 2026, with 9.55% growth. This brings the company's revenue in the last twelve months to 16.38B, up 16.26% year-over-year. In the year 2025, KMPHARMACEUTICAL had annual revenue of 15.99B with 10.47% growth.

• Revenue (ttm): 16.38B
• Revenue Growth: +16.26%
• P/S Ratio: 0.80
• Revenue / Employee: 282.40M
• Employees: 58
• Market Cap: 13.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.99B	1.52B	10.47%
Dec 31, 2024	14.47B	-3.29B	-18.54%
Dec 31, 2023	17.77B	2.14B	13.68%
Dec 31, 2022	15.63B	-7.07B	-31.15%
Dec 31, 2021	22.71B	-223.00M	-0.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error